| Time | Topics | Speaker/s |
|
11:00
-
11:12
|
Gene Therapy in IRDs: From RPE65 to CRISPR-Based Approaches
|
Reza Mirshahi, MD
|
|
11:12
-
11:15
|
Question and Answer
|
|
|
11:15
-
11:27
|
Cell Therapy in Retinal Degenerative Diseases:What is in Pipeline in 2025?
|
Masood Naseripour, MD
|
|
11:27
-
11:30
|
Question and Answer
|
|
|
11:30
-
11:42
|
Gene Therapy for AMD, DR, and DME: Anti-VEGF, Complement Modulation, Sustained Delivery
|
Narges Hassanpoor, MD
|
|
11:42
-
11:45
|
Question and Answer
|
|
|
11:45
-
11:57
|
Pediatric Retinal Disorders and ROP: Stem Cell and Neuroprotective Strategies
|
Fatemeh Bazvand, MD
|
|
11:57
-
12:00
|
Question and Answer
|
|
|
12:00
-
12:12
|
Optogenetics and Vision Restoration
|
Zahra Soheila Soheili, PhD
|
|
12:12
-
12:15
|
Question and Answer
|
|
|
12:15
-
12:27
|
Gene Silencing and RNA-Based Therapies in Retinal Diseases
|
Elaheh Asadollahi, PhD
|
|
12:27
-
12:30
|
Question and Answer
|
|
|
12:30
-
13:00
|
Panel Discussion
|
|